Korea's National Core Technology Protection 2026: What Foreign Investors Must Know

Table of Contents

Introduction: The 2026 Shift in Korea’s Investment Landscape

South Korea has significantly tightened its regulatory framework for foreign investment in companies holding National Core Technologies (NCT) and National Advanced Strategic Technologies (NAST). The recent amendments to the Industrial Technology Protection Act (ITA), effective in 2026, reflect Korea’s commitment to safeguarding critical technologies while maintaining an attractive environment for foreign capital.

For foreign investors eyeing M&A deals, joint ventures, or equity stakes in Korean tech companies, understanding these new rules isn’t optional—it’s essential. A misstep can result in deal rejection, severe fines, or even criminal liability.

This guide breaks down what changed in 2026, who it affects, and how to stay compliant.

What Are National Core Technologies (NCT)?

National Core Technologies are technologies deemed vital to Korea’s economic security and competitiveness. These include:

• Semiconductors (advanced chip design, manufacturing processes)
• Display technologies (OLED, quantum dot displays)
• Secondary batteries (lithium-ion, solid-state batteries)
• Shipbuilding (LNG carriers, offshore platforms)
• Biotechnology (vaccine development, gene therapy)
• AI and big data (machine learning algorithms, data processing)

The Ministry of Trade, Industry and Energy (MOTIE) maintains a designated list, updated periodically. As of 2026, the list covers over 70 specific technology categories across multiple sectors.

National Advanced Strategic Technologies (NAST) represent an even higher tier—technologies critical to national security, such as military-grade semiconductors, quantum computing, and nuclear fusion.

The 2026 ITA Amendment: What Changed?

Prior Approval and Reporting Requirements

Previously, foreign investment in NCT-holding companies faced review after the transaction. The 2026 amendment shifts this to prior approval or notification.

Key thresholds:

Control isn’t just about share percentage. MOTIE considers:

• Board representation
• Veto rights over key decisions
• Technology access agreements
• Management contracts

Even minority stakes can trigger scrutiny if the investor gains effective control over NCT-related operations.

Enhanced Penalties

The stakes are higher in 2026:

• Fines: Up to KRW 3 billion (previously KRW 1 billion) for procedural violations
• Imprisonment: Up to 7 years (previously 3 years) for technology leakage or unapproved transfers
• Transaction voidance: MOTIE can unwind deals retroactively if violations are discovered

For publicly traded companies, non-compliance can also trigger stock exchange penalties and reputational damage.

Expanded Scope of “Foreign Investment”

The amendment clarifies that indirect acquisitions also require approval:

• Acquiring a foreign parent company that owns a Korean NCT subsidiary
• Mergers involving foreign entities with Korean NCT holdings
• Fund investments where foreign LPs gain influence over Korean portfolio companies

This closes loopholes that previously allowed foreign investors to bypass scrutiny through offshore structures.

Approval Process: Step-by-Step

Step 1: Self-Assessment

Before approaching MOTIE, determine:

1. Does the target company hold NCT or NAST? (Check MOTIE’s published list)
2. What percentage of shares will you acquire?
3. Will you gain control or significant influence?
4. Is the investment direct or indirect?

If unsure, request a preliminary consultation with MOTIE’s Foreign Investment Division. This non-binding dialogue can clarify whether formal approval is needed.

Step 2: Filing for Approval

Required documents:

• Transaction structure diagram
• Target company’s NCT portfolio (technology descriptions, patents, trade secrets)
• Investor’s business plan (intended use of NCT, commercialization strategy)
• Security measures (data protection, personnel restrictions)
• Foreign government ties (if any)

Processing time:

• Standard cases: 30-60 days
• Complex cases (NAST, sensitive sectors): 90-120 days

MOTIE may request additional information, extending timelines. Plan for at least 90 days from initial filing to final approval.

Step 3: Conditional Approvals

MOTIE often grants approval with conditions:

• Technology firewalls: Restricting foreign access to certain R&D data
• Board observer roles only: No voting rights on NCT-related decisions
• Periodic reporting: Quarterly updates on technology use and transfers
• Exit clauses: Requirements to divest if national security concerns arise

Violating these conditions can trigger retroactive penalties, so meticulous compliance tracking is essential.

Step 4: Post-Approval Obligations

After closing:

• Notify MOTIE within 30 days of transaction completion
• Annual compliance reports for 5 years
• Ad hoc notifications for any material changes (e.g., secondary sales, technology licensing)

Failure to report can result in fines even if the original approval was properly obtained.

Practical Strategies for Foreign Investors

1. Early Due Diligence

Don’t wait until the LOI stage to assess NCT exposure. During initial target screening:

• Request patent portfolios and R&D roadmaps
• Interview technical staff about proprietary technologies
• Review government grants or subsidies (often linked to NCT projects)

Korean sellers may downplay NCT issues to keep deals on track. Independent verification is critical.

2. Build Regulatory Buffers into Timelines

If your acquisition timeline is:

• 6 months: Add 3 months for NCT approval
• 12 months: Add 4-5 months for complex cases

Share purchase agreements should include regulatory approval conditions with extended long-stop dates. Consider break fees to compensate if MOTIE denies approval.

3. Engage Local Counsel Early

Korean law firms specializing in FDI and tech M&A can:

• Pre-screen NCT exposure
• Draft MOTIE submissions
• Negotiate conditions with regulators
• Monitor post-closing compliance

SMA Lawfirm has extensive experience guiding foreign investors through NCT approvals, from initial assessments to final clearance.

4. Structure Around Restrictions

If full acquisition isn’t feasible, consider:

• Joint ventures with Korean partners (shared control structures)
• Technology licensing agreements (instead of equity stakes)
• Earn-out mechanisms tied to NCT approval milestones

These alternatives can achieve commercial objectives while reducing regulatory friction.

5. Prepare for “No”

MOTIE can deny approvals, especially if:

• The investor is state-backed (sovereign wealth funds, government entities)
• The technology has dual-use (military + civilian) applications
• National security concerns arise (geopolitical tensions)

Have Plan B ready: alternative targets, restructured deals, or exit strategies.

Case Studies: 2026 in Practice

Case 1: Semiconductor Equipment Acquisition

A U.S. private equity firm sought to acquire a 60% stake in a Korean company producing advanced lithography equipment (NCT-designated).

Outcome: MOTIE granted conditional approval after 120 days, requiring:

• A Korean national as CEO
• Restricted access to proprietary software for foreign board members
• Annual audits of technology security protocols

The PE firm accepted the conditions but renegotiated the purchase price down 15% to reflect operational constraints.

Case 2: Battery Tech Joint Venture

A Chinese battery manufacturer proposed a 50-50 JV with a Korean solid-state battery startup (NAST-designated).

Outcome: Denied. MOTIE cited “national security concerns” given the investor’s ties to a Chinese state-owned enterprise. The Korean startup pivoted to a Japanese investor, which received approval in 45 days.

Lesson: Investor nationality and government affiliations matter. Korean regulators scrutinize Chinese and Russian investors more closely in sensitive sectors.

Case 3: Indirect Acquisition via Luxembourg Holdco

A European fund acquired a Luxembourg holding company that owned 70% of a Korean display tech firm (NCT-designated). The fund assumed no NCT approval was needed since the direct transaction was in Europe.

Outcome: MOTIE fined the fund KRW 2 billion for failing to seek prior approval. The fund was required to file retroactively, delaying exit plans by 18 months.

Lesson: Indirect acquisitions aren’t exempt. Always trace ultimate ownership to Korean entities.

FAQ: Common Questions

Q1: What if my target develops NCT after I invest?

You must notify MOTIE within 90 days if the target is designated as an NCT holder post-acquisition. MOTIE may impose new conditions or require partial divestment.

Q2: Can I appeal a denial?

Yes. Appeals must be filed within 60 days of the denial notice. However, success rates are low (~10%). Focus on addressing MOTIE’s concerns in the initial submission.

Q3: Do venture capital minority stakes trigger approval?

Generally, no—if you hold less than 10% with no board seats or veto rights. But if your investment terms include technology access or IP licensing, MOTIE may require notification.

Q4: How do I know if a technology is NCT-designated?

MOTIE publishes the list at www.motie.go.kr. It’s updated semi-annually. When in doubt, request a formal designation confirmation from MOTIE.

Q5: What about portfolio companies in Korea-focused funds?

If your fund is managed from abroad but invests in Korean companies, each portfolio investment is assessed individually. Fund-level aggregation isn’t automatic, but MOTIE may review cumulative exposure across multiple portfolio companies.

Key Takeaways

• NCT protection is serious: 2026 amendments significantly expand MOTIE’s authority and penalties.
• Prior approval is the default: Don’t assume you can invest first and ask questions later.
• Indirect structures don’t escape scrutiny: Luxembourg holdcos, offshore SPVs—all are caught.
• Plan for delays: 90-120 days is the new normal for tech M&A in Korea.
• Conditions are negotiable (sometimes): Work with experienced counsel to shape acceptable compromises.
• Non-compliance is expensive: Fines, imprisonment, and deal unwinding are real risks.

How SMA Lawfirm Can Help

Navigating Korea’s NCT regime requires deep regulatory expertise and strategic foresight. SMA Lawfirm offers:

• Pre-transaction NCT screenings (technology audits, designation confirmations)
• MOTIE approval filings (document preparation, regulator liaison)
• Conditional approval negotiations (minimizing operational restrictions)
• Post-closing compliance management (reporting, monitoring)

We’ve successfully guided Fortune 500 companies, PE funds, and strategic investors through complex NCT approvals across semiconductors, biotech, and AI sectors.

📩 Contact us today: sma@saemunan.com

Let’s ensure your Korean investment succeeds—compliantly and efficiently.

Conclusion

Korea’s 2026 NCT protection framework reflects a global trend: balancing foreign investment with national security. For foreign investors, ignorance isn’t bliss—it’s liability.

Start your due diligence early, engage local experts, and build regulatory approvals into your deal structure from day one. The right preparation turns compliance from a roadblock into a competitive advantage.

Ready to invest in Korean tech? Make sure you’re on the right side of MOTIE’s new rules.